These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35431240)

  • 1. Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    Sheng C; Yang K; He B; Li T; Wang X; Du W; Hu X; Jiang J; Jiang X; Jessen F; Han Y
    J Alzheimers Dis; 2022; 87(3):1319-1333. PubMed ID: 35431240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.
    Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW;
    Alzheimers Res Ther; 2023 Aug; 15(1):132. PubMed ID: 37550761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.
    Li X; Wang X; Su L; Hu X; Han Y
    BMJ Open; 2019 Jul; 9(7):e028188. PubMed ID: 31350244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.
    Jiang X; Hu X; Daamen M; Wang X; Fan C; Meiberth D; Spottke A; Roeske S; Fliessbach K; Spruth EJ; Altenstein S; Lohse A; Hansen N; Glanz W; Incesoy EI; Dobisch L; Janowitz D; Rauchmann BS; Ramirez A; Kilimann I; Munk MH; Wang X; Schneider LS; Gabelin T; Roy N; Wolfsgruber S; Kleineidam L; Hetzer S; Dechent P; Ewers M; Scheffler K; Amthauer H; Buchert R; Essler M; Drzezga A; Rominger A; Krause BJ; Reimold M; Priller J; Schneider A; Wiltfang J; Buerger K; Perneczky R; Teipel S; Laske C; Peters O; Düzel E; Wagner M; Jiang J; Jessen F; Boecker H; Han Y
    Alzheimers Dement; 2023 Nov; 19(11):4922-4934. PubMed ID: 37070734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
    Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
    Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol.
    Mazzeo S; Lassi M; Padiglioni S; Vergani AA; Moschini V; Scarpino M; Giacomucci G; Burali R; Morinelli C; Fabbiani C; Galdo G; Amato LG; Bagnoli S; Emiliani F; Ingannato A; Nacmias B; Sorbi S; Grippo A; Mazzoni A; Bessi V
    BMC Neurol; 2023 Aug; 23(1):300. PubMed ID: 37573339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle Cognitive Deficits Are Associated with Amyloid-β Positivity, but Not Severity of Self-Reported Decline: Results from the CoSCo Study.
    Ryu SY; Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW
    Dement Geriatr Cogn Disord; 2022; 51(2):159-167. PubMed ID: 35381591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    Sheng C; Lin L; Lin H; Wang X; Han Y; Liu SL
    J Alzheimers Dis; 2021; 82(2):513-526. PubMed ID: 34024839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts.
    Shao K; Hu X; Kleineidam L; Stark M; Altenstein S; Amthauer H; Boecker H; Buchert R; Buerger K; Butryn M; Cai Y; Cai Y; Cosma NC; Chen G; Chen Z; Daamen M; Drzezga A; Düzel E; Essler M; Ewers M; Fliessbach K; Gaertner FC; Glanz W; Guo T; Hansen N; He B; Janowitz D; Kilimann I; Krause BJ; Lan G; Lange C; Laske C; Li Y; Li R; Liu L; Lu J; Meng F; Munk MH; Peters O; Perneczky R; Priller J; Ramirez A; Rauchmann BS; Reimold M; Rominger A; Rostamzadeh A; Roy-Kluth N; Schneider A; Spottke A; Spruth EJ; Sun P; Teipel S; Wang X; Wei M; Wei Y; Wiltfang J; Yan S; Yang J; Yu X; Zhang M; Zhang L; ; Wagner M; Jessen F; Han Y; Kuhn E
    Alzheimers Dement; 2024 Sep; 20(9):5926-5939. PubMed ID: 39072956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
    Jessen F; Wolfsgruber S; Kleineindam L; Spottke A; Altenstein S; Bartels C; Berger M; Brosseron F; Daamen M; Dichgans M; Dobisch L; Ewers M; Fenski F; Fliessbach K; Freiesleben SD; Glanz W; Görß D; Gürsel S; Janowitz D; Kilimann I; Kobeleva X; Lohse A; Maier F; Metzger C; Munk M; Preis L; Sanzenbacher C; Spruth E; Rauchmann B; Vukovich R; Yakupov R; Weyrauch AS; Ziegler G; Schmid M; Laske C; Perneczky R; Schneider A; Wiltfang J; Teipel S; Bürger K; Priller J; Peters O; Ramirez A; Boecker H; Heneka MT; Wagner M; Düzel E
    Alzheimers Dement; 2023 Feb; 19(2):487-497. PubMed ID: 35451563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer's disease.
    Göschel L; Kurz L; Dell'Orco A; Köbe T; Körtvélyessy P; Fillmer A; Aydin S; Riemann LT; Wang H; Ittermann B; Grittner U; Flöel A
    Neuroimage Clin; 2023; 38():103439. PubMed ID: 37253284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
    Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
    Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results.
    Slot RER; Verfaillie SCJ; Overbeek JM; Timmers T; Wesselman LMP; Teunissen CE; Dols A; Bouwman FH; Prins ND; Barkhof F; Lammertsma AA; Van Berckel BNM; Scheltens P; Sikkes SAM; Van der Flier WM
    Alzheimers Res Ther; 2018 Aug; 10(1):76. PubMed ID: 30081935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
    Funaki K; Nakajima S; Noda Y; Wake T; Ito D; Yamagata B; Yoshizaki T; Kameyama M; Nakahara T; Murakami K; Jinzaki M; Mimura M; Tabuchi H
    Psychogeriatrics; 2019 Jul; 19(4):325-332. PubMed ID: 30688000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cognitive deterioration in subjective cognitive decline: evidence from longitudinal studies and implications for SCD-plus criteria.
    Li H; Tan CC; Tan L; Xu W
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):844-854. PubMed ID: 36868847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.